Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome changes associated with targeting mTORC2 in lung squamous cell carcinoma

ABSTRACT: Transcriptome changes associated with targeting mTORC2 in lung squamous cell carcinoma

PROVIDER: PRJNA1123287 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR29379426_1.fastq.gz	Fastqsanger.gz
	SRR29379426_2.fastq.gz	Fastqsanger.gz
	SRR29379427_1.fastq.gz	Fastqsanger.gz
	SRR29379427_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 7

Similar Datasets

Transcriptome changes associated with targeting mTORC2 in lung squamous cell carcinoma

Project description:Lung squamous cell carcinoma (LUSC) represents 30% of NSCLC and is associated with high mortality and a lack of therapies. Targeted therapies for lung adenocarcinoma (LUAD) improve overall survival, but such advances have not been made for treatment of LUSC irrespective of frequent molecular abnormalities. Immune checkpoint inhibitor therapies have achieved some success in LUSC patients. However, most patients do not respond adequately to such treatment, thereby patients are left with fewer specific treatment options. Exploring vulnerabilities in NSCLC, we showed that a high percentage of LUSC patients bear genetic alterations in the PI3K-mTOR-AKT signaling pathway. Loss of function of mTORC2 in LUSC cells inhibits glycolysis and lactate secretion in cultured cells and tumor growth in vivo. The goal of this study was to investigate how targeting mTORC2 impacts LUSC and the tumor microenvironment, which can be harness for therapeutic options.

2024-10-31 | GSE269711 | GEO

Quantitative proteomic profiling lung squamous carcinoma cells

Project description:Quantitative proteomic profiling the lung squamous carcinoma cells

2016-07-14 | MSV000079911 | MassIVE

Therapeutic targeting of BRD4 in head neck squamous cell carcinoma

Project description:Therapeutic targeting of BRD4 in head neck squamous cell carcinoma

| PRJNA505480 | ENA

Human- lung squamous cell carcinoma LC-MS/MS Orbitrap Fusion

Project description:Integration of LC-MS/MS data links biological processes to fragmentation of tumor epithelia, and morphological marker that associates with decreased patient survival in lung squamous cell carcinoma

2017-05-15 | PXD006132 | Pride

Squamous cell carcinoma of the lung

Project description:Squamous cell carcinoma of the lung

| PRJNA172762 | ENA

Quantitative proteomic analysis of lung adenocarcinoma and squamous cell carcinoma primary tissues using high resolution mass spectrometry

Project description:Lung cancer is the leading cause of preventable death globally and is broadly classified into adenocarcinoma and squamous cell carcinoma depending upon cell type. In this study, we carried out mass spectrometry based quantitative proteomic analysis of lung adenocarcinoma and squamous cell carcinoma primary tissue by employing the isobaric tags for relative and absolute quantitation (iTRAQ) approach. Proteomic data was analyzed using SEQUEST search algorithm which resulted in identification of 25,998 peptides corresponding to 4,342 proteins of which 610 proteins were differentially expressed (≥ 2-fold) between adenocarcinoma and squamous cell carcinoma samples. These differentially expressed proteins were further classified by gene ontology for their localizations and biological processes. Pathway analysis of differentially expressed proteins revealed distinct alterations in networks and pathways in both adenocarcinoma and squamous cell carcinoma samples. In this study, we identified a subset of proteins that shows converse expression between lung adenocarcinoma and squamous cell carcinoma samples. Such proteins may serve as signature markers to distinguish between the two subtypes.

2018-10-02 | PXD008700 | Pride

Human lung squamous cell carcinoma expression profiling

Project description:Lung squamous cell carcinoma gene expression (LSCC) is highly variable. This study discovered and validated LSCC gene expression subtypes.

2010-08-06 | GSE17710 | GEO

Gene expression profiling of asbestos-related lung squamous cell carcinoma

Project description:To identify gene expression biomarkers associate with asbestos-related lung squamous cell carcinoma, we analyzed gene expression profiles for a total of 56 lung squamous cell carcinomas using 44K Illumina Gene Expression microarrays. Twenty-six cases had lung asbestos body counts above levels associated with urban dwelling (ARLC-SCC: asbestos-related lung cancer-squamous cell carcinoma) and 30 cases had no lung asbestos bodies (NARLC-SCC: non-asbestos related lung cancer- squamous cell carcinoma). Genes differentially expressed between ARLC-SCC and NARLC-SCC were identified on fold change and P-value, and then prioritised using gene ontology. Total RNA was obtained from fresh frozen lung tumour tissue and stratified by asbestos phenotype. Gene expression profiling was performed to identify differences in the gene profiles of asbestos-related and non-asbestos related lung squamous cell carcinomas.

2012-01-30 | E-GEOD-23822 | biostudies-arrayexpress

Gene expression profiling of asbestos-related lung squamous cell carcinoma

2012-01-30 | GSE23822 | GEO

microRNA expression in lung squamous cell carcinoma cell lines

Project description:microRNA expression data from AstraZeneca internal squamous cell carcinoma cell line panel

2015-12-01 | GSE73774 | GEO